I however think it’s important for African countries to have their own independent regulatory authorities because we’ve seen examples of first line drugs that work great in the West not necessarily work as efficiently for African populations, for example in antihypertensives, anti failure drugs etc. I thus believe African countries developing their own health data is key in the long run and a focus on streamlining market accessibility for new drugs THAT WORK FOR AFRICAN POPULATIONS is key.
Hi Nick,
I do get the “perceived sovereignty” angle.
I however think it’s important for African countries to have their own independent regulatory authorities because we’ve seen examples of first line drugs that work great in the West not necessarily work as efficiently for African populations, for example in antihypertensives, anti failure drugs etc. I thus believe African countries developing their own health data is key in the long run and a focus on streamlining market accessibility for new drugs THAT WORK FOR AFRICAN POPULATIONS is key.